ATLANTA, Georgia — A combination of gene-expression testing (BronchoGen, Allegro Diagnostics) and diagnostic bronchoscopy significantly improves accuracy in the diagnosis of lung cancer, compared with ...

Biomarker testing is crucial for personalized oncology care, aiding in risk stratification and treatment decisions, but faces ...

Yale researchers recently discovered new genes that could be used to test potential treatment options for a rare form of aggressive lung cancer. Each year, about 6,000 Americans — roughly 3 percent of ...

In A Nutshell Johns Hopkins researchers developed a blood test that catches 81% of stage IA lung cancers (the earliest, most ...

Young lung cancer patients have a higher incidence of targetable biomarkers, necessitating comprehensive testing for ALK fusions and EGFR mutations. Repeat biomarker testing is essential when ...

Dr Mark Kris discusses the increasing precision of lung cancer therapies and the need for additional testing to find ...

When Beverley Moir, a lifelong non-smoker, developed a second lingering cold within six months, she was coughing so severely she thought she had strep throat. She booked an appointment with her family ...

An emerging oncology tool known as broad genomic profiling or BGP is increasingly being used to help identify targeted therapies for patients diagnosed with cancer. Rather than analyzing one gene at a ...

Understanding those genetic “errors” has become central to modern lung cancer care. Biomarker testing, sometimes called ...

Personalized treatment strategies are increasingly important in managing lung cancer brain metastases, incorporating targeted therapies and immunotherapies. Stereotactic radiosurgery and whole-brain ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.